NMS Capital has exited its investment in Flourish Research, a US-based clinical trial organization, through a sale to Genstar Capital. No financial terms were disclosed.

Just one year after introducing the world’s first burn nursing specialty certification, the Board of Certification for Emergency Nursing (BCEN) proudly reports that nearly 500 nurses in both civilian ...

Lonza’s innovative continuous flow technology and mini-monoplant approach are transforming early-phase drug development. How ...

Jason Gerberry, an analyst from Bank of America Securities, reiterated the Sell rating on Galapagos (GLPG – Research Report). The ...

biomodal, an omics-based life sciences technology and analytics company, today announced it will present new data highlighting the utility of duet mul ...

Damansara Specialist Hospital 2 (DSH2) launched its Less Scars, Less Pain campaign to educate the public on how its primary focus on safe, precise and minimally-invasive surgery innovations promote ...

Parkinson's disease (PD) and Alzheimer's disease (AD) are examples of brain illnesses that begin to develop in patients far ...

Cencora, Inc. (NYSE: COR) today announced that it has entered into a definitive agreement to acquire Retina Consultants of America ("RCA"), a leading management services organization (MSO) of retina ...

The clinical research industry is a booming one, with a global value standing at over US$480bil last year, and it is ...

Immunis, Inc., a clinical-stage biotech developing novel secretomes for age-related diseases and immune dysfunction, has ...

Sweden: A recent review published in Best Practice & Research Clinical Anaesthesiology has highlighted the evolution of ...

Electro-acupuncture may help manage obesity by reducing osteoprotegerin, a protein tied to fat cell growth. This TCM approach ...